Pramipexole for stage 2 treatment-resistant major depression: An open study

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 8, 2010, Pages 1446-1449

  Inoue, Takeshi ^a   Kitaichi, Yuji ^a   Masui, Takuya ^a   Nakagawa, Shin ^a   Boku, Shuken ^a   Tanaka, Teruaki ^a   Suzuki, Katsuji ^a   Nakato, Yasuya ^a   Usui, Reiko ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Augmentation therapy; Dopamine receptor agonist; Mood disorder; Pramipexole; Treatment resistant depression

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; CLOMIPRAMINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MIANSERIN; MILNACIPRAN; NORTRIPTYLINE; PAROXETINE; PRAMIPEXOLE; SERTRALINE;

ADJUVANT THERAPY; ADULT; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; DISEASE CLASSIFICATION; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; IRRITABILITY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOTION SICKNESS; NAUSEA; OPEN STUDY; SIDE EFFECT; TREATMENT RESISTANT MAJOR DEPRESSION;

ADULT; BENZOTHIAZOLES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78649499726     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.07.035     Document Type: Article

References (28)

1. Aiken C.B. Pramipexole in psychiatry: a systematic review of the literature. J Clin Psychiatry 2007, 68:1230-1236.
2. Bauer M., Whybrow P.C., Angst J., Versiani M., Möller H.J. World Federation of Societies Biological Psychiatry Task Force on Treatment Guidelines for Unipolar Depressive Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 2002, 3:5-43.
3. Bouckoms A., Mangini L. Pergolide: an antidepressant adjuvant for mood disorders?. Psychopharmacol Bull 1993, 29:207-211.
4. Carmody T.J., Rush A.J., Bernstein I., Warden D., Brannan S., Burnham D., et al. The Montgomery Åsberg and the Hamilton ratings of depression: a comparison of measures. Eur Neuropsychopharmacol 2006, 16:601-611.
5. Cassano P., Lattanzi L., Fava M., Navari S., Battistini G., Abelli M., et al. Ropinirole in treatment-resistant depression: a 16-week pilot study. Can J Psychiatry 2005, 50:357-360.
6. Corrigan M.H., Denahan A.Q., Wright C.E., Ragual R.J., Evans D.L. Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. Depress Anxiety 2000, 11:58-65.
7. Fitzgerald P.B., Benitez J., de Castella A., Daskalakis Z.J., Brown T.L., Kulkarni J. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry 2006, 163:88-94.
8. Furukawa T.A., Takeuchi H., Hiroe T., Mashiko H., Kamei K., Kitamura T., et al. Symptomatic recovery and social functioning in major depression. Acta Psychiatr Scand 2001, 103:257-261.
9. Goldberg J.F., Burdick K.E., Endick C.J. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Am J Psychiatry 2004, 161:564-566.
10. Haykal R.F., Akiskal H.S. The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management. J Clin Psychiatry 1999, 60:508-518.
11. Inoue T., Tsuchiya K., Miura J., Sakakibara S., Denda K., Kasahara T., et al. Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression. Biol Psychiatry 1996, 40:151-153.
12. Inoue T., Izumi T., Koyama T. Strategy of augmentation therapy for refractory depression. Recent Advances in the Research of Affective Disorders in Japan 2002, 147-151. Elsevier Science, Amsterdam. T. Okuma, Y. Inoue, S. Kanba (Eds.).
13. Inoue T., Nakagawa S., Kitaichi Y., Izumi T., Tanaka T., Masui T., et al. Long-term outcome of antidepressant-refractory depression: the relevance of unrecognized bipolarity. J Affect Disord 2006, 95:61-67.
14. Izumi T., Inoue T., Kitagawa N., Nishi N., Shimanaka S., Takahashi Y., et al. Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depression. J Affect Disord 2000, 61:127-132.
15. Jaspers K. Allgemine Psychopathologie 1973, Springer-Verlag, Berlin.
16. Lattanzi L., Dell'Osso L., Cassano P., Pini S., Rucci P., Houck P.R., et al. Pramipexole in treatment-resistant depression: a 16-week naturalistic study. Bipolar Disord 2002, 4:307-314.
17. Marcus R.N., McQuade R.D., Carson W.H., Hennicken D., Fava M., Simon J.S., et al. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol 2008, 28:156-165.
18. Montgomery S.A., Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389.
19. O'Reardon J.P., Solvason H.B., Janicak P.G., Sampson S., Isenberg K.E., Nahas Z., et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007, 62:1208-1216.
20. Papakostas G.I. Dopaminergic-based pharmacotherapies for depression. Eur Neuropsychopharmacol 2006, 16:391-402.
21. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006, 163:1905-1917.
22. Sharma V., Khan M., Smith A. A closer look at treatment resistant depression: is it due to a bipolar diathesis?. J Affect Disord 2005, 84:251-257.
23. Sporn J., Ghaemi S.N., Sambur M.R., Rankin M.A., Recht J., Sachs G.S., et al. Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review. Annal Clin Psychiatry 2000, 12:137-140.
24. Stimpson N., Agrawal N., Lewis G. Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression: systematic review. Br J Psychiatry 2002, 181:284-294.
25. Thase M.E., Rush A.J. Treatment-resistant depression. Psychopharmacology: The Fourth Generation of Progress 1995, 1081-1097. Raven Press, New York. F.E. Bloom, D.J. Kupfer (Eds.).
26. Thase M.E., Corya S.A., Osuntokun O., Case M., Henley D.B., Sanger T.M., et al. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder. J Clin Psychiatry 2007, 68:224-236.
27. Williams J.B. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1988, 45:742-747.
28. Zarate C.A., Payne J.L., Singh J., Quiroz J.A., Luckenbaugh D.A., Denicoff K.D., et al. Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biol Psychiatry 2004, 56:54-60.